<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04772092</url>
  </required_header>
  <id_info>
    <org_study_id>BARBEN 2020</org_study_id>
    <nct_id>NCT04772092</nct_id>
  </id_info>
  <brief_title>Impact of Age and Geriatric Co-morbidities on Lymphocyte Phenotype in Patients 70 Years of Age and Older</brief_title>
  <acronym>PHENOGERIA</acronym>
  <official_title>Impact of Age and Geriatric Co-morbidities on Lymphocyte Phenotype in Patients 70 Years of Age and Older</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An individual's immune profile changes with age, and can sometimes be involved in the&#xD;
      development of certain diseases such as infections or cancers, in a process called&#xD;
      immunosenescence. Some data tend to show that there is a link between this immune profile and&#xD;
      geriatric fragility (autonomy, difficulties with walking, memory, undernutrition,&#xD;
      co-morbidities, depression). The aim of this study is to describe this profile, or immune&#xD;
      phenotype, and to see if there is a link with the different aspects of geriatric assessment&#xD;
      in patients without cancer or infection. In addition, these data will serve as a basis for&#xD;
      comparison with the same analyses performed on breast cancer patients at the Centre Georges&#xD;
      François Leclerc.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of immune cells in peripheral blood</measure>
    <time_frame>At inclusion</time_frame>
    <description>technique used: flow cytometry</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Geriatrics Immunosenescence</condition>
  <arm_group>
    <arm_group_label>Seniors</arm_group_label>
    <description>70 years of age and over, inpatients or outpatients</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood samples</intervention_name>
    <description>during the routine blood test, collection of additional blood samples:&#xD;
1 x 5 mL heparinized tube for plasma collection and storage&#xD;
1 heparinized 5 mL tube for immunophenotyping&#xD;
4 x 10 mL EDTA tubes for white blood cell (WBC) collection and cryopreservation</description>
    <arm_group_label>Seniors</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection</intervention_name>
    <description>clinical examination data&#xD;
test results to measure the degree of geriatric fatigability&#xD;
Frailty screening questionnaire for neoplasia patients (G8 score)</description>
    <arm_group_label>Seniors</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A person at least 70 years of age admitted to the Champmaillot Geriatric Center on an&#xD;
        inpatient or outpatient basis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Person who has not opposed to inclusion in the study&#xD;
&#xD;
          -  Male or female aged 70 and over admitted to the Champmaillot Geriatric Center on an&#xD;
             inpatient or outpatient basis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Person not affiliated to national health insurance system&#xD;
&#xD;
          -  Person subject to a measure of legal safeguard (curatorship, etc)&#xD;
&#xD;
          -  Person with an acute infection&#xD;
&#xD;
          -  Person with suspected cancer or active cancer&#xD;
&#xD;
          -  Long-term immunosuppressive or corticosteroid therapy&#xD;
&#xD;
          -  HIV and/or HBV and/or HCV positive serology&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Jérémy BARBEN</last_name>
    <phone>03 80 29 30 17</phone>
    <email>jeremy.barben@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Jérémy BARBEN</last_name>
      <phone>03 80 29 30 17</phone>
      <email>jeremy.barben@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 24, 2021</study_first_submitted>
  <study_first_submitted_qc>February 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

